Experimental drug offers new hope for coeliac disease treatment – protects the whole body from the harmful effects of gluten (IMAGE)

University of Oulu, Finland

Experimental drug offers new hope for coeliac disease treatment – protects the whole body from the harmful effects of gluten

Caption

Gluten triggers an inflammatory response in the intestine of a person with coeliac disease, which can be prevented by inhibiting the activity of transglutaminase 2 (TG2). The new study shows that an experimental TG2 inhibitor also dampens the effects of gluten on lipid and protein metabolism as well as at the epigenetic level, meaning its effects extend widely throughout the body. Image: Keijo Viiri. The image was created using BioRender software (BioRender.com).

Credit

Image: Keijo Viiri. The image was created using BioRender software (BioRender.com).

Usage Restrictions

The image may be used freely, provided the source is credited, when reporting on the press release.

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.